Walder Wyss advises Cosaic on $ 6m seed fundingg round
Walder Wyss advised Swiss food biotech startup Cosaic throughout completion of a USD 6 million late seed financing round. The funds will support the company’s path to market readiness across three key areas: regulatory work, production scale-up, and industrial trials with large clients.
The investor base
The financing round brought in a mix of new and returning investors. New participants include dsm-firmenich Ventures, a large Swiss family office, and Kickfund. Existing investors Navus Ventures and Zürcher Kantonalbank also participated in the round.
The Walder Wyss team
The Walder Wyss team working on the matter included partners Ramona Wyss (transactions/regulatory, pictured), and Fabienne Limacher (tax, pictured), senior associate Letizia Schlegel (corporate/M&A), associate Merens Derungs (corporate/M&A), associate Johannes Stamm (IP/IT), senior associiate Benjamin Reis (commercial contracts), and associate Mounia Stocker (employment).
